Results 91 to 100 of about 228,636 (318)

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy

Frontiers in Oncology, 2018
Immune checkpoint inhibitors targeting the programmed cell death receptor 1 (PD-1) are increasingly used to treat several malignancies, with the most common adverse event being cutaneous toxicity.
Marie Donaldson, Joshua L. Owen, Young K. Chae, Young K. Chae, Jennifer N. Choi, Jennifer N. Choi   +5 more
doaj   +1 more source

Allergic Contact Dermatitis Due to Sodium Metabisulfite in a Bleaching Cream

, 2008
A 52-year-old lady presented with chloasma on bilateral zygomatic areas for several years. She was prescribed with a bleaching cream, Shines®, containing 4% hydroquinone as the active component.
HUANG, PEI-YING;CHU, CHIA-YU, 黃沛盈;朱家瑜   +1 more
core  

Lack of improvement after short‐term topical antistaphylococcal endolysin SA.100 therapy in patients with mild‐to‐moderate atopic dermatitis: Results from a randomized, vehicle‐controlled trial

British Journal of Clinical Pharmacology, EarlyView.
Abstract Atopic dermatitis (AD) is a chronic immune‐mediated inflammatory skin disease. An overgrowth of Staphylococcus aureus (S. aureus) and decreased microbial diversity is apparent in 70%–90% of AD patients. SA.100 is a recombinant endolysin targeting S. aureus that might be a novel treatment for patients with mild‐to‐moderate AD.
Laura W. J. van der Meulen, Menthe E. Bergmans, Salma Assil, Ismahaan Abdisalaam, Rianne Rijneveld, Erica S. Klaassen, Alexa J. Tibboel, Thorsten Brach, Bjorn L. Herpers, Johan Frieling, Benthe Freyee, Karin Platenkamp, Mariette E. van Poelgeest, Robert Rissmann, Martijn B. A. van Doorn, Tessa Niemeyer – van der Kolk   +15 more
wiley   +1 more source

Predictors of occupational skin disease among seafood processing workers in the Western Cape

, 2012
Includes bibliographical references.Occupational skin disease is common in seafood processing workers. While previous studies have reported an increased prevalence of symptoms (as high as 50%) and protein contact dermatitis (3-11%), the prevalence and ...
Burdzik, Amy
core  

S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double‐blind randomized clinical trial in patients with mild to moderate atopic dermatitis

British Journal of Clinical Pharmacology, EarlyView.
Aim Recovering dysbiosis may improve atopic dermatitis (AD) symptoms. XZ.700 is a recombinant chimeric endolysin that specifically targets Staphylococcus aureus and could be a new treatment option for patients with AD. The aim of this first‐in‐human study was to evaluate the safety, tolerability and efficacy of topical XZ.700 and explore the ...
Laura W. J. van der Meulen, Menthe E. Bergmans, Salma Assil, Naomi Klarenbeek, Marieke L. de Kam, Alexa J. Tibboel, Thorsten Brach, Bjorn L. Herpers, Johan Frieling, Vincent de Jong, Benthe Freyee, Martijn B. A. van Doorn, Robert Rissmann, Tessa Niemeyer–van der Kolk   +13 more
wiley   +1 more source

Paederus dermatitis

Indian Journal of Dermatology, Venereology and Leprology, 2017
Paederus dermatitis is an irritant dermatitis caused by pederin, a toxin produced by the rove beetle (Paederus). The disease occurs worldwide, but it is often not recognized as a history of contact with the insect is frequently absent. It is commonly seen in the rainy season.
Kaliaperumal, Karthikeyan, Annapurna, Kumar   +1 more
openaire   +2 more sources

Lost and found in translation: the value of the human imiquimod model

British Journal of Clinical Pharmacology, EarlyView.
Topical imiquimod (IMQ), a Toll‐like receptor (TLR) 7 agonist, induces transient cutaneous inflammation and is widely used in preclinical research as a ‘psoriasis‐like’ mouse model. However, accumulating evidence indicates substantial divergence between IMQ‐driven biology and human plaque psoriasis pathogenesis.
Anouk C. Meijs, Juliette A. van den Noort, Salma Assil, Naomi B. Klarenbeek, Matthijs Moerland, Tessa Niemeyer‐van der Kolk, Robert Rissmann   +6 more
wiley   +1 more source

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

Clinical and Translational Allergy, 2023
Lotte S. Spekhorst, Marlies deGraaf, Lisa P. van derRijst, Nicolaas P. A. Zuithoff, René C. Schweizer, Marijke Kamsteeg, Inge Haeck, Anneke M. T. vanLynden‐van Nes, Paula vanLumig, Geertruida L. E. Romeijn, Marie‐Louise Schuttelaar, Marjolein S. deBruin‐Weller   +11 more
doaj   +1 more source

Diagnóstico preliminar de la molestia sanitaria causada por Culicoides (Diptera: Ceratopogonidae) en el departamento de Boyacá, Colombia

Biomédica: revista del Instituto Nacional de Salud, 2008
Introducción. Los habitantes del occidente del departamento de Boyacá han reportado molestia sanitaria y problemas dermatológicos ocasionados por la constante picadura de insectos del género Culicoides. Objetivo.
Erika Santamaría, Olga Lucía Cabrera, Yaneth Zipa, Cristina Ferro, Martha Liliana Ahumada, Raúl Hernando Pardo   +5 more
doaj   +1 more source